1. Brock N. und Hohorst H.-J. (1963): Über die Aktivierung von Cyclophosphamid in vivo und in vitro. Arzneimittel-Forsch.,13, 1021–1031.
2. Cohen J.L. and Jao J.Y. (1970): Enzymatic basis of cuclophosphamide activation by hepatic microsomes of the rat. J. Pharmac. exp. Ther.,174, 206–210.
3. Connors T.A., Cox P.J., Farmer P.B., Foster A.B. and Jarman M. (1974): Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem. Pharmac,23, 115–129.
4. Foley G.E., Friedman O.M. and Drolet BJP. (1961): Studies on the mechanism of action of Cytoxan: Evidence of activationin vivo andin vitro. Cancer Res.,21, 57–63.
5. Hill D.L., Laster W.R. Jr. and Struck R.F. (1972): Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite. Cancer Res.,32, 658–665.